Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
Factor VIII is a blood clotting protein that helps your body form stable clots after injury. The test measures the functional activity of factor VIII in your plasma, typically using a clot-based method, to see how well the protein works rather than simply how much is present.
It is commonly ordered with other coagulation tests when there is unexplained bleeding or a prolonged clotting time. It helps diagnose and monitor hemophilia A and can also aid in assessing conditions that affect factor VIII function or level.
Too little factor VIII activity can lead to easy bruising or bleeding, including joint or muscle bleeds, heavy menstrual bleeding, or prolonged bleeding after procedures. Markedly low activity is characteristic of hemophilia A, while mild reductions can be seen in von Willebrand disease or after certain illnesses.
Factor VIII can also rise with inflammation, stress, pregnancy, or estrogen therapy. Persistently high factor VIII activity has been associated with an increased tendency for blood clots in veins. Your clinician may use this test to evaluate bleeding, to monitor therapy, or as part of an assessment for clotting risk.
If your activity is lower than expected, your clinician may repeat the test and review how the sample was collected, then consider follow-up studies such as von Willebrand factor testing, a mixing study, or an inhibitor screen. These can help distinguish inherited hemophilia A from an acquired inhibitor or other causes of abnormal clotting tests.
If your activity is higher than expected, your clinician will consider temporary factors like recent illness, stress, pregnancy, or hormone use. Results are interpreted together with your symptoms and other labs. Depending on the overall picture, next steps may include observation, treatment planning, genetic counseling, or strategies to reduce clotting risk.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Underfilled or overfilled blue-top citrate tubes, difficult draws, clotted samples, delays before centrifugation, or improper storage can falsely change factor VIII activity. Ensure the tube is filled to the mark and processed promptly.
Factor VIII is an acute phase reactant, so infection, inflammation, surgery, trauma, or vigorous exercise can raise levels temporarily. Testing when you are well gives a more stable baseline.
Desmopressin and factor VIII concentrates elevate measured activity. Some agents, including emicizumab and certain anticoagulants, can interfere with clot-based assays. Tell your care team about all medicines and infusions.
Estrogen-containing contraceptives or hormone therapy and pregnancy can increase factor VIII activity. Your clinician may interpret results in that context or time testing accordingly.
People with blood group O often have lower baseline von Willebrand factor, which can be accompanied by lower factor VIII activity. Levels can also rise gradually with age.
Plasma transfusion or factor replacement before testing may transiently normalize or elevate activity and mask an underlying deficiency. Let the laboratory know about recent blood products.
References